12 results · 20ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

SUTTER ELECTROSURGICAL CABLES

FDA 510(k)
FDA Class 2 ·General, Plastic Surgery

NOTTA AMBULATORY RECORDER

FDA 510(k)
FDA Class 2 ·Neurology

INTRASTENT DOUBLESTRUT PARAMOUNT BILIARY ENDOPROSTHESIS

FDA 510(k)
FDA Class 2 ·Gastroenterology, Urology

GYNECARE MORCELLEX* TISSUE MORCELLATOR

FDA Adverse Event
Malfunction ·ETHICON, INC.·Product code HET·April 23, 2013

ACCESS® 2 IMMUNOASSAY SYSTEM

FDA Adverse Event
Malfunction ·BECKMAN COULTER INC.·Product code JJE·May 1, 2011

TENDRIL SDX

FDA Adverse Event
Injury ·ST JUDE MEDICAL CARDIAC RHYTHM MANAGEMENT DIVISION·Product code DTB·July 11, 2008

ORTHOPEDIC SALVAGE SYSTEM BEARING

FDA Adverse Event
Injury ·ZIMMER BIOMET, INC.·Product code JDI·November 28, 2017

ORTHOPEDIC SALVAGE SYSTEM YOKE

FDA Adverse Event
Injury ·ZIMMER BIOMET, INC.·Product code KRO·November 28, 2017

ORTHOPEDIC SALVAGE SYSTEM AXLE

FDA Adverse Event
Injury ·ZIMMER BIOMET, INC.·Product code JDI·November 28, 2017

ORTHOPEDIC SALVAGE SYSTEM LOCKING PIN

FDA Adverse Event
Injury ·ZIMMER BIOMET, INC.·Product code JDI·November 28, 2017

ORTHOPEDIC SALVAGE SYSTEM FEMORAL BUSHING

FDA Adverse Event
Injury ·ZIMMER BIOMET, INC.·Product code JDI·November 28, 2017

Stryker MA204 Bed Model (FL25E) Beds are intended for medical purposes in both general patient care as well as critical care environments. Each uses built-in electric motors and controls which can be operated by the patient, or caregiver, to adjust the height and/or surface contour of the bed.The devices listed above also include movable and latchable side rails which can be lowered or raised to help prevent patient fall and subsequent injury. The Beds include an optional Scale (Models: FL20E, FL25E, FL28C, FL28EX) as well as an optional Bed Exit (1 Zone) or Chaperone

FDA Enforcement
Class II ·Terminated·Stryker Medical Division of Stryker Corporation·July 4, 2012